Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| PRECISION BIOSCIENCES INCDTIL · Entity 6284 | Director | June 03, 2026 | June 05, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
PRECISION BIOSCIENCES INC
Report date June 03, 2026 · Filed June 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 20,979 |
Reported balance
After 2026-06-03 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-06-03 · Grant · Acquired 20,979 · Balance 20,979 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F2: The RSUs vest on the earlier to occur of (i) June 3, 2027 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
F2: The RSUs vest on the earlier to occur of (i) June 3, 2027 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 03, 2026 Filed Jun 5, 2026 11:35 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | GrantRestricted Stock Units · Derivative | 20,979 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-041037 · wk-form4_1780659321.xml · derivative · entry 1 Buehler Kevin · CIK 0001792722 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,979 Underlying: Common Stock · 20,979 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F2 · derivative.exercise_date: The RSUs vest on the earlier to occur of (i) June 3, 2027 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. F2 · derivative.expiration_date: The RSUs vest on the earlier to occur of (i) June 3, 2027 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. Read SEC document |
| May 20, 2026 Filed May 22, 2026 11:31 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | Exercise / conversionRestricted Stock Units · Derivative | 21,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-037539 · wk-form4_1779449504.xml · derivative · entry 2 Buehler Kevin · CIK 0001792722 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 21,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. F3 · derivative.exercise_date: On June 3, 2025 the Reporting person was granted RSUs. The RSUs vested on the earlier to occur of (i) June 3, 2026 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. F3 · derivative.expiration_date: On June 3, 2025 the Reporting person was granted RSUs. The RSUs vested on the earlier to occur of (i) June 3, 2026 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. Read SEC document |
| May 20, 2026 Filed May 22, 2026 11:31 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | Exercise / conversionCommon Stock | 21,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-037539 · wk-form4_1779449504.xml · nonDerivative · entry 1 Buehler Kevin · CIK 0001792722 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,137 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the vesting of Restricted Stock Units ("RSUs") on May 20, 2026. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| June 25, 2025 Filed Jun 27, 2025 10:14 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | PurchaseCommon Stock | 5,076 | $4.16 | $21,116.16 |
DisclosureSEC source: 0001628280-25-033199 · wk-form4_1751019253.xml · nonDerivative · entry 1 Buehler Kevin · CIK 0001792722 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,137 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.16 to $4.18. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote. Read SEC document |
| June 03, 2025 Filed Jun 4, 2025 21:00 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | GrantRestricted Stock Units · Derivative | 21,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-081725 · ownership.xml · derivative · entry 3 Buehler Kevin · CIK 0001792722 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,000 Underlying: Common Stock · 21,000 shares Expires not disclosed F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. F4 · derivative.exercise_date: The RSUs vest on the earlier to occur of (i) June 3, 2026 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. F4 · derivative.expiration_date: The RSUs vest on the earlier to occur of (i) June 3, 2026 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. Read SEC document |
| May 27, 2025 Filed Jun 4, 2025 21:00 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | Exercise / conversionRestricted Stock Units · Derivative | 9,826 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-081725 · ownership.xml · derivative · entry 2 Buehler Kevin · CIK 0001792722 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,826 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. F3 · derivative.exercise_date: On June 4, 2024 the Reporting person was granted RSUs. The RSUs vested on the earlier to occur of (i) June 4, 2025 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. F3 · derivative.expiration_date: On June 4, 2024 the Reporting person was granted RSUs. The RSUs vested on the earlier to occur of (i) June 4, 2025 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. Read SEC document |
| May 27, 2025 Filed Jun 4, 2025 21:00 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | Exercise / conversionCommon Stock | 9,826 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-081725 · ownership.xml · nonDerivative · entry 1 Buehler Kevin · CIK 0001792722 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,061 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the vesting of Restricted Stock Units ("RSUs") on May 27, 2025. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| March 26, 2025 Filed Mar 28, 2025 11:02 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | PurchaseCommon Stock | 4,523 | $4.67 | $21,122.41 |
DisclosureSEC source: 0000950170-25-046331 · ownership.xml · nonDerivative · entry 1 Buehler Kevin · CIK 0001792722 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,235 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.62 to $4.67. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote. Read SEC document |
| December 27, 2024 Filed Dec 31, 2024 12:00 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | PurchaseCommon Stock | 4,320 | $4.88 | $21,081.60 |
DisclosureSEC source: 0000950170-24-141309 · ownership.xml · nonDerivative · entry 1 Buehler Kevin · CIK 0001792722 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,712 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.73 to $4.94. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote. Read SEC document |
| June 04, 2024 Filed Jun 6, 2024 20:37 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | GrantRestricted Stock Units · Derivative | 9,826 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-069941 · ownership.xml · derivative · entry 1 Buehler Kevin · CIK 0001792722 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,826 Underlying: Common Stock · 9,826 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such shares. F2 · derivative.exercise_date: The RSUs vest on the earlier to occur of (i) June 4, 2025 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. F2 · derivative.expiration_date: The RSUs vest on the earlier to occur of (i) June 4, 2025 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. Read SEC document |
| May 04, 2024 Filed May 7, 2024 20:26 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | Exercise / conversionRestricted Stock Units · Derivative | 4,202 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-054586 · ownership.xml · derivative · entry 2 Buehler Kevin · CIK 0001792722 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,202 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. F4 · derivative.exercise_date: On May 4, 2023 the Reporting Person was granted RSUs. The RSUs vested in full on May 4, 2024. F4 · derivative.expiration_date: On May 4, 2023 the Reporting Person was granted RSUs. The RSUs vested in full on May 4, 2024. Read SEC document |
| May 04, 2024 Filed May 7, 2024 20:26 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | Exercise / conversionCommon Stock | 4,202 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-054586 · ownership.xml · nonDerivative · entry 1 Buehler Kevin · CIK 0001792722 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,392 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the vesting and settlement of Restricted Stock Units ("RSUs") on May 4, 2024. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. F3 · balance_after: On February 13, 2024, the Issuer effected a 1-for-30 reverse stock split. The amounts of securities herein have been adjusted to reflect the reverse stock split. Read SEC document |
| May 04, 2023 Filed May 8, 2023 20:15 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | GrantRestricted Stock Units · Derivative | 126,075 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-027926 · doc4.xml · derivative · entry 1 Buehler Kevin · CIK 0001792722 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 126,075 Underlying: Common Stock · 126,075 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such shares. F2 · derivative.exercise_date: The RSUs vest on the earlier to occur of (i) May 4, 2024 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. F2 · derivative.expiration_date: The RSUs vest on the earlier to occur of (i) May 4, 2024 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. Read SEC document |
| April 11, 2023 Filed Apr 13, 2023 20:15 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | Exercise / conversionRestricted Stock Units · Derivative | 5,701 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-024206 · doc4.xml · derivative · entry 2 Buehler Kevin · CIK 0001792722 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,701 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. F3 · derivative.exercise_date: On April 11, 2022 the Issuer granted RSUs to the Reporting Person in connection with the Reporting Person's service as Chair of the Board. The RSUs vested in full on April 11, 2023. F3 · derivative.expiration_date: On April 11, 2022 the Issuer granted RSUs to the Reporting Person in connection with the Reporting Person's service as Chair of the Board. The RSUs vested in full on April 11, 2023. Read SEC document |
| April 11, 2023 Filed Apr 13, 2023 20:15 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | Exercise / conversionCommon Stock | 5,701 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-024206 · doc4.xml · nonDerivative · entry 1 Buehler Kevin · CIK 0001792722 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,701 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the vesting and settlement of Restricted Stock Units ("RSUs") on April 11, 2023 F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| May 10, 2022 Filed May 12, 2022 11:12 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | GrantStock Option (Right to Buy) · Derivative | 156,951 | $0.00 Strike: $1.86 | $0.00 |
DisclosureSEC source: 0001209191-22-028443 · doc4.xml · derivative · entry 1 Buehler Kevin · CIK 0001792722 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,951 Underlying: Common Stock · 156,951 shares Expires 2032-05-09 F1 · derivative.exercise_date: The option vests on the earlier to occur of (i) May 10, 2023 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. Read SEC document |
| April 11, 2022 Filed Apr 13, 2022 21:00 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | GrantRestricted Stock Units · Derivative | 5,701 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-024302 · doc4.xml · derivative · entry 2 Buehler Kevin · CIK 0001792722 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,701 Underlying: Common Stock · 5,701 shares Expires not disclosed F2 · derivative.exercise_price: The Reporting Person was granted restricted stock units ("RSUs"), which each represent a contingent right to receive one share of the Company's Common Stock. F3 · derivative.exercise_date: The RSUs shall be fully vested on the first anniversary of the grant date of such RSUs, subject to the Reporting Person continuing in service through each such vesting date. F3 · derivative.expiration_date: The RSUs shall be fully vested on the first anniversary of the grant date of such RSUs, subject to the Reporting Person continuing in service through each such vesting date. Read SEC document |
| April 11, 2022 Filed Apr 13, 2022 21:00 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | GrantStock Option (Right to Buy) · Derivative | 8,763 | $0.00 Strike: $2.85 | $0.00 |
DisclosureSEC source: 0001209191-22-024302 · doc4.xml · derivative · entry 1 Buehler Kevin · CIK 0001792722 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,763 Underlying: Common Stock · 8,763 shares Expires 2032-04-10 F1 · derivative.exercise_date: The option vests in 12 substantially equal monthly installments following April 11, 2022, such that the option shall be fully vested on April 11, 2023, subject to the Reporting Person continuing in service through each such vesting date. Read SEC document |
| May 10, 2021 Filed May 12, 2021 20:01 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | GrantStock Option (Right to Buy) · Derivative | 32,800 | $0.00 Strike: $8.07 | $0.00 |
DisclosureSEC source: 0001209191-21-032011 · doc4.xml · derivative · entry 1 Buehler Kevin · CIK 0001792722 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,800 Underlying: Common Stock · 32,800 shares Expires 2031-05-09 F1 · derivative.exercise_date: The option vests on the earlier of May 10, 2022 or the day immediately prior to the date of the next annual meeting of the Company's stockholders occurring after May 10, 2021, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. Read SEC document |
| May 13, 2020 Filed May 15, 2020 20:00 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | GrantStock Option (Right to Buy) · Derivative | 41,038 | $0.00 Strike: $6.62 | $0.00 |
DisclosureSEC source: 0001209191-20-029691 · doc4.xml · derivative · entry 1 Buehler Kevin · CIK 0001792722 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,038 Underlying: Common Stock · 41,038 shares Expires 2030-05-12 F1 · derivative.exercise_date: The option vests on the earlier of May 13, 2021 or the day immediately prior to the date of the next annual meeting of the Company's stockholders occurring after May 13, 2020. Read SEC document |
| November 08, 2019 Filed Nov 13, 2019 12:15 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | GrantStock Option (Right to Buy) · Derivative | 60,776 | $0.00 Strike: $9.00 | $0.00 |
DisclosureSEC source: 0001209191-19-056253 · doc4.xml · derivative · entry 1 Buehler Kevin · CIK 0001792722 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,776 Underlying: Common Stock · 60,776 shares Expires 2029-11-08 F1 · derivative.exercise_date: The option vests in 36 substantially equal monthly installments following November 8, 2019, such that the option shall be fully vested on November 8, 2022. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.